Peer Review History
| Original SubmissionNovember 16, 2021 |
|---|
|
PONE-D-21-36401A method to quantitate maternal transcripts localized in sea urchin egg cortex by RT-qPCR with accurate normalizationPLOS ONE Dear Dr. Yakovlev, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 05 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Wei Cui, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: [This work was supported by the Russian Foundation for Basic Research (Grant number: 20-04-00332). The authors are grateful to Dr. Andrey Kukhlevsky for Sanger sequencing.] We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: [NO] Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 5. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. Additional Editor Comments: Both expert reviewers found this manuscript interesting. However, several major questions were also pointed out and authors need to address them in their revision. Please refer to the reviewers' comments for details. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This study attempts to use RT-qPCR as a means of quantitating maternal mRNA transcripts in the cortex of sea urchin eggs. The paper concentrates on the evaluation of seven potential reference genes that are ranked based on the results of five different methods and then indicates that the gene of interest Daglb-2 shows increased levels of mRNA in cortices relative to the best reference genes. I have the following comments about this research. Major Points: 1) Unlike the case with Xenopus, C. elegans or Drosophila eggs, very few polarized maternal proteins or mRNAs have been identified in sea urchin eggs. This despite extensive research effort over several decades. The sea urchin early embryo is often cited as a prime example of a highly regulative embryo with irreversible polarization setting up only once the embryo has reached the 16 cell stage. The authors suggest that RT-qPCR would be useful for the identification of maternal mRNAs that are potentially enriched in the cortex. They indicate that the mRNA for the genes Panda (ref 14) and Coup-TF (refs 16, 17) are associated with subcortical areas of oocytes, eggs, and embryos. However, although in situ hybridization (ISH) imaging does suggest a gradient of Panda in oocytes, cortical association is not clear and even the Panda gradient itself is not obvious in eggs (Fig 5 in ref 14). In addition, the apparent cortical association of Coup-TF in the oocyte/egg appears to be present in only two of three sea urchin species tested (refs 16, 17). Given that these mRNAs have some literature precedence for cortical association it would make sense to use then as targets for the RT-qPCR experiment that the authors conduct in the present study. However, the authors indicate that they excluded these transcripts because they were unable to identify a Panda homologue in their species and that the G-C rich nature of Coup-TF made it difficult to amplify via RT-qPCR. Instead they choose to focus on the transcript of the gene Daglb-2 which they indicate was identified by transcriptomic analysis. The authors need to provide additional details about the nature of how this transcriptomic analysis was performed and what were the results. For example, were cortices isolated in a similar manner? Did other transcripts show cortical enrichment? Also, a biological role for the suggested cortical localization of the Daglb-2 protein is not provided. Do the authors have a hypothetical rationale why endocannabinoid signaling would be subject to polarized maternal distribution? They suggest that the transcript is localized in the cortex because of a need for local translation and integration into the membrane. Are the authors aware of precedence in the sea urchin for the localized cortical translation of membrane proteins? In general, the authors need to provide a better argument about why they ended up focusing on Daglb-2. 2) Given that this is a “proof-of-concept” study it is important that the authors provide the appropriate documentation of their methods. The description that they give in the Materials and Methods section of the cortex isolation process (page 5-6) is inadequate and incomplete. In addition, they need to provide low and high magnification phase contrast microscopy images of the cortical preparations that they generate for RNA isolation. These images would make it clear how intact the cortices were, to include the presence or absence of cortical granules. 3) This study would be greatly improved by providing RNA FISH localization evidence of the cortical association of Daglb-2. This evidence would help validate the results of their RT-qPCR results. The senior author has previously published work involving confocal microscopy of the immunofluorescent localization of proteins in sea urchin egg cortices (ref 19) so the expertise and imaging instrumentation is available. In addition, it would be important to provide FISH and/or ISH images of Daglb-2 in whole oocytes, eggs and early embryos. Minor Points: 1) The paper needs to be carefully edited for proper English grammar, word choice and sentence structure. In its current form, it is sometimes difficult to decipher the meaning of what is written. 2) What type of statistical analysis was performed on the data in Fig 4? T tests? ANOVA? 3) The fact that Daglb-2 transcripts were found to be cortex-enriched only in mRNA and not in total RNA analysis is puzzling. The authors should speculate on what might be causing this difference. Reviewer #2: In this manuscript, authors tried to establish a method for quantitate maternal genes in eggs of a sea urchin, Strongylocentrotus intermedius. Especially, authors tried to find the stable reference gene, which is essential for the qPCR analysis. Personally, I recognize this interesting, but I also have concerns. Obtaining RNA and the usage of template RNA for cDNA synthesis look not appropriate. For example, authors showed Ct in Fig1, in which authors treat the data as absolute quantity. However, authors obtained RNA from countless eggs and set RNA to 1 µg to synthesize cDNA. If the authors need the absolute quantity, the authors need to count the number of eggs, to use one/two step RT-qPCR kit, by which we do not have to change tubes, and same egg-number volume of cDNA should be applied into each qPCR tube. In another example, the protocol of cortex isolation is not stable (although the authors described it stable). This is because nobody can expect how much % of egg cortex are remained on the coverslip. In addition, RNA composition might be different between each pole of the egg since the protein localization is different between animal and vegetal poles. I also have a question how much maternal mRNA is trapped by poly(A) selection. It is well known that poly-adenylation system starts at the fertilization, meaning that un-fertilized eggs contain a number of non-poly(A) RNA. So, it is better for authors to explain such RNA characteristics (if I were wrong, please ignore this point). Therefore, if the authors intend to make “standard” methods for maternal RT-qPCR for eggs/cortex, initially it is necessary to set the protocol much more precisely in each step. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
An approach to quantitate maternal transcripts localized in sea urchin egg cortex using RT-qPCR with accurate normalization PONE-D-21-36401R1 Dear Dr. Yakovlev, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Wei Cui, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Questions and concerns have been addressed. Reviewers' comments: |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .